Cannabis Law Report

JULY 8, 2021

The Company expects to finalize the agreement with the research institute and commence studies by Fall 2021. Following the execution of this work, cbdMD Therapeutics will perform the requisite toxicological studies with Ion Tox, a leading in vitro toxicology and ADME-PK testing company, to support the safety of the cannabinoids of interest.

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

Cannabis Law Report

JUNE 17, 2021

VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) — Brains Bioceutical Corp. Brains is one of a few companies in the world producing CBD as an API for pharmaceutical applications, research, development, and clinical trials. CBD and zero Tetrahydrocannabinol (THC).

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Events 105

Healer

DECEMBER 17, 2021

November 5, 2021. The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. A recent animal study found that, unlike THC, CBD actually raised intraocular pressure.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

JULY 14, 2021

(“ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. ImmunoFlex has submitted non-provisional ( USA ) and PCT (international) patent applications based on the research carried out by ImmunoFlex in 2020 and 2021. federal law.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

Cannabis Law Report

JUNE 4, 2021

With Delta 8, one is not going to have an anxious or paranoia episode as can be common for newcomers to marijuana forms of cannabis – especially with high concentration of THC that is readily available today. The legal cannabis industry is expected to exceed $40 billion in 2021 and CBD sales should reach $5 billion.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Healer

DECEMBER 17, 2021

November 5, 2021. The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. A recent animal study found that, unlike THC, CBD actually raised intraocular pressure.

CBD 52

CBD THC Conditions Medicine 52

The Cannigma

DECEMBER 12, 2022

Just as THCA in cannabis flower needs to be decarboxylated into the active compound THC, psilocybin is not active until it undergoes a chemical reaction. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Iboga safety: Numerous concerns about the safety of iboga have been raised by scientists.

History 119

History Microdosing Research and Development Clinical Trials 119

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Previously a Schedule I substance, hemp was reclassified; hemp has extremely low levels of THC (less than 0.3%).

Research and Development 117

Research and Development Education Agriculture Patients 117

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. in 2021 reached $2 billion, according to Statistica.)

CBD 144

CBD Seed-To-Sale Food Access 144

The Cannigma

JANUARY 13, 2023

Based on the limited existing evidence, the best cannabis strain for migraines may be a Type II that includes both THC and CBD, and a terpene profile that includes beta-caryophyllene, myrcene, linalool, limonene, bisabolol, humulene or pinene. 5 THC and migraines THC is well-known for its anti-nausea and pain-relieving effects.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

OCTOBER 22, 2021

The “Medical Marijuana – Cannabidiol – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. Medical Marijuana – Cannabidiol – Pipeline Insight, 2021” report provides comprehensive insights for about 25+ companies and 50+ pipeline drugs in Medical Marijuana – Cannabidiol pipeline landscape.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

OCTOBER 18, 2021

DUBLIN–(BUSINESS WIRE)–The “Medical Marijuana – Cannabidiol – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. Currently, the two main cannabinoids from the marijuana plant that are of medical interest are THC and CBD. BX-1: Bionorica SE.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

The Cannigma

OCTOBER 19, 2021

A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. A 2010 study found that consuming alcohol “slightly prolonged” the half-life of THC in the blood.

Research and Development 128

Research and Development Clinical Trials Edibles THC 128

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 20, 2021

s NORML Coordinator Dale Gieringer, Delta-8 has undergone minimal testing in humans, “therefore, little is known about its long-term safety, its consumption at high dosages, or its medicinal effects.” Additionally, the advocacy group views Delta-8 THC as a Schedule I substance under federal law. According to Calif.’s Law 360 (sub.

Hemp 52

Hemp Clinical Trials CBD Legalization 52

Puff Puff Post

DECEMBER 28, 2018

THC – the main molecule responsible for feeling high, stoned, or any effects associated with weed isn’t used for treatment. The cannabinoids were administered in two different formulations, both of which had a ratio of 20:1 for CBD to THC. CBD Oil For Autism: How Can Cannabis Help? Instead, CBD is being used.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

JUNE 4, 2021

This list is focused on those who have had the largest impact for 2021. . Tim Ferriss is Psychedelics Invest’s number one most influential person for 2021 because of his support through his funding, utilization of his multiple massive social outlets, and his continued balanced message about the efficacy and realities of psychedelic medicines.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51